Iain D. Dukes, Director at IOVANCE BIOTHERAPEUTICS, INC. (IOVA), bought 32,000 shares at $9.15 ($293K) on 2024-02-20, disclosed to the SEC on 2024-02-20.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |